(C) Residual Specimens shall be used and shared for only the following purposes, subject to specimen availability as determined by the Newborn Blood Screening Program:

1. (1) Laboratory Quality Assurance, including laboratory quality control, laboratory validation, participation in proficiency testing, and the practice of continuous quality improvements;
2. (2) Individual or family clinical benefit with individual or parent/guardian authorization in writing;
3. (3) Individual or family forensic purposes with individual or parent/guardian authorization in writing;
4. (4) Uses authorized by law including, but not limited to, an investigation of a child death by a state or local child fatality review team pursuant to M.G.L. c. 38, § 2A, at the request of the local district attorney, or by the Office of the Chief Medical Examiner pursuant to M.G.L. c. 38, § 4, at the request of the Chief Medical Examiner, or his or her designee, in order to establish the cause and manner of death and identity of the deceased;